Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Scilex Holding Company ( (SCLX) ) has provided an update.
Scilex Holding Company has announced a change in the record date for its previously announced dividend of Series 1 Mandatory Exchangeable Preferred Stock. The new record date is set for January 28, 2025, replacing the earlier date of November 7, 2024. This adjustment impacts the timeline for the dividend’s payment, which will occur within 60 days after the new record date, pending board approval. This change reflects Scilex’s ongoing strategic decisions impacting its financial operations and shareholder relations.
More about Scilex Holding Company
Scilex Holding Company is an innovative, revenue-generating company based in Palo Alto, California, focused on developing and commercializing non-opioid pain management products for acute and chronic pain. It aims to target high unmet needs with large market opportunities, offering products like ZTlido for neuropathic pain, ELYXYB for migraines, and Gloperba for gout. The company is also advancing product candidates for pain and fibromyalgia, and plans a joint venture for neurodegenerative and cardiometabolic disease.
YTD Price Performance: -80.88%
Average Trading Volume: 2,160,637
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $93.27M
For detailed information about SCLX stock, go to TipRanks’ Stock Analysis page.